Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey

Journal of Medical Virology

Volumn 80, Issue 1, 2008, Pages 53-57

  Nascimento, Maria Claudia ^a,b   Mayaud, Philippe ^c   Sabino, Ester Cerdeira ^d   Torres, Katia Luz ^e   Franceschi, Silvia ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Blood Center of São Paulo   (Brazil)

^e Fundacao de Hematologia e Hemoterapia do Amazonas   (Brazil)

Author keywords

Blood donors; Brazil; Epidemiology; Hepatitis B virus (HBV); Hepatitis C virus (HCV); Seroprevalence

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BRAZIL; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNIC GROUP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; SEXUALITY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 36849015049     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21046     Document Type: Article

References (20)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. 2006. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144:705-714.
2. Arraes LC, Ximenes R, Andrieu JM, Lu W, Barreto S, Pereira LM, Castelo A. 2003. The biological meaning of anti-HBC positive result in blood donors: Relation to HBV-DNA and to other serological markers. Rev Inst Med Trop Sao Paulo 45:137-140.
3. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. 2007. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: Implications for transfusion practice. Transfusion 47:74-79.
4. Braga WS, Brasil LM, de Souza RA, Castilho MC, da Fonseca JC. 2001. The occurrence of hepatitis B and delta virus infection within seven Amerindian ethnic groups in the Brazilian western Amazon. Rev Soc Bras Med Trop 34:349-355.
5. Chen H, Cantrell CR. 2006. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis. Curr Med Res Opin 22:2489-2496.
6. Christensen PB, Titlestad IL, Homburg KM, Georgsen J, Kristensen T. 2001. Hepatitis B core antibodies in Danish blood donors: A surrogate marker of risk behaviour. Vox Sang 81:222-227.
7. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. 2000. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 18:2345-2350.
8. Gish RG, Gadano AC. 2006. Chronic hepatitis B: Current epidemiology in the Americas and implications for management. J Viral Hepat 13:787-798.
9. Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R. 2006. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 11:951-954.
10. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. 1999. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 89:14-18.
11. Molijn MH, van der Linden JM, Ko LK, Gorgels J, Hop W, van Rhenen DJ. 1997. Risk factors and anti-HBc reactivity among first time blood donors. Vox Sang 72:207-210.
12. Parkin DM. 2006. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044.
13. Salles NA, Sabino EC, Barreto CC, Barreto AM, Otani MM, Chamone DF. 2003. The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of Sao Paulo, Sao Paulo, Brazil. Rev Panam Salud Publica 13:111-116.
14. Silveira TR, da Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, Clemens SA. 1999. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 6:378-383.
15. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. 2005. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 150:2513-2528.
16. Valente VB, Covas DT, Passos AD. 2005. Hepatitis B and C serologic markers in blood donors of the Ribeirao Preto Blood Center. Rev Soc Bras Med Trop 38:488-492.
17. Vasconcelos HC, Yoshida CF, Vanderborght BO, Schatzmayr HG. 1994. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Mem Inst Oswaldo Cruz 89:503-507.
18. Wang B, Schreiber GB, Glynn SA, Kleinman S, Wright DJ, Murphy EL, Busch MP. 2005. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Transfusion 45:1089-1096.
19. Wiwanitkit V. 2005. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematology 10:431-433.
20. World Health Organization. 2004. Hepatitis B vaccines. Wkly Epidemiol Rec 79:255-263.